Dr. Juan Camilo Arjona Ferreira - 27 May 2022 Form 4 Insider Report for Myovant Sciences Ltd.

Role
Chief Medical Officer
Signature
/s/ Matthew Lang, Attorney-in-fact
Issuer symbol
N/A
Transactions as of
27 May 2022
Net transactions value
-$13,917
Form type
4
Filing time
01 Jun 2022, 16:20:46 UTC
Previous filing
21 Apr 2022
Next filing
08 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MYOV Common Shares Sale $13,917 -1,382 -0.53% $10.07 258,747 27 May 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I.